Design Therapeutics, Inc. (DSGN:NASDAQ) closed at $10.24 on October 23, 2026, down 2.38% on the day. The stock trades 40.6% below its 52-week high of $17.25 and 79.5% above its 52-week low of $5.71. Over the past year, it gained 78.7%. Design Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, DSGN closed higher on 132 days (52%). Its best day was April 29, 2026 (+23.26%) and its worst was May 18, 2026 (-25.54%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 2 times.
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Find more stocks like DSGN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.